The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

Korean Circ J. 2017 Mar;47(2):179-181. doi: 10.4070/kcj.2017.0011. Epub 2017 Mar 8.

Author

Affiliation

¹ Department of Pediatrics, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

No abstract available

Publication types

Editorial